Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis

Table 1 Clinicopathological data of the 10 ESCC cases

Sample No.	Age	Gender	Site	Pathological grade	Size (cm)	Lymphatic invasion	TNM stage
1	58	Male	Upper	Moderately differentiated	3	Negative	II
2	67	Female	Middle	Moderately differentiated	5	Positive	III
3	55	Male	Middle	Well differentiated	2	Negative	I
4	62	Male	Middle	Moderately differentiated	2	Negative	I
5	62	Male	Upper	Moderately differentiated	2.5	Negative	II
6	52	Male	Middle	Poorly differentiated	4	Negative	II
7	61	Male	Middle	Moderately differentiated	3	Negative	II
8	55	Female	Lower	Poorly differentiated	6	Positive	IV
9	70	Male	Lower	Moderately differentiated	5	Positive	III
10	53	Male	Middle	Poorly differentiated	3	Positive	II

ISSN: 1471-2407